Abstract: Backgroud Pulmonary arterial hypertension(PAH) is a common systemic disease. The study found the site of injury in patients with pulmonary hypertension associated with pulmonary vascular smooth muscle cell energy metabolism, glucose transporter (GLUT-1) abnormally high expression. Objective the aim of this review is to discuss the role of GLUT-1 in PAH, provide new therapeutic strategies for the treatment of PAH. Content At first,the characteristics of GLUT-1 were introduced.Secondly, we explored the mechanism of disease increases in PAH.Trend GLUT-1 may be a new target for the treatment of PAH, providing new directions for the treatment of PAH.
|